Literature DB >> 25228705

Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults.

Aggrey Mweemba1, Arianna Zanolini2, Lloyd Mulenga3, Drew Emge2, Benjamin H Chi4, Gilles Wandeler5, Michael J Vinikoor2.   

Abstract

Among 6789 HIV-infected Zambian adults screened for hepatitis B virus (HBV) coinfection, estimated glomerular filtration rate (eGFR) was 50-90 mL/minute/1.73 m(2) in 17.6% and <50 mL/minute/1.73 m(2) in 2.5%. Human immunodeficiency virus/HBV coinfection was associated with eGFR <50 mL/minute/1.73 m(2) (adjusted odds ratio, 1.96 [95% confidence interval, 1.34-2.86]), adjusted for age, sex, CD4(+) count, and World Health Organization disease stage.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Africa; HIV/AIDS; hepatitis B virus; renal dysfunction; tenofovir

Mesh：

Substances：

Year:  2014        PMID： 25228705      PMCID： PMC4311179          DOI： 10.1093/cid/ciu734

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

1.  Hepatitis B virus and HIV coinfection in low-income countries: unmet needs.

Authors:  Massimo Puoti; Daniela Manno; Paola Nasta; Giampiero Carosi
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

Authors:  Andrew S Levey; Paul E de Jong; Josef Coresh; Meguid El Nahas; Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Bertram L Kasiske; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

3.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

4.  Membranous nephropathy related to hepatitis B virus in adults.

Authors:  K N Lai; P K Li; S F Lui; T C Au; J S Tam; K L Tong; F M Lai
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

5.  Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.

Authors:  Lloyd Mulenga; Patrick Musonda; Albert Mwango; Michael J Vinikoor; Mary-Ann Davies; Aggrey Mweemba; Alexandra Calmy; Jeffrey S Stringer; Olivia Keiser; Benjamin H Chi; Gilles Wandeler
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

Review 6.  Clinical implications of HIV and hepatitis B co-infection in Asia and Africa.

Authors:  Christopher J Hoffmann; Chloe L Thio
Journal:  Lancet Infect Dis       Date:  2007-06       Impact factor: 25.071

7.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

8.  Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania.

Authors:  Claudia Hawkins; Beatrice Christian; Jitao Ye; Tumaini Nagu; Eric Aris; Guerino Chalamilla; Donna Spiegelman; Ferdinand Mugusi; Saurabh Mehta; Wafaie Fawzi
Journal:  AIDS       Date:  2013-03-27       Impact factor: 4.177

9.  Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.

Authors:  Amanda Mocroft; Jacqueline Neuhaus; Lars Peters; Lene Ryom; Markus Bickel; Daniel Grint; Janak Koirala; Aleksandra Szymczak; Jens Lundgren; Michael J Ross; Christina M Wyatt
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240
  9 in total
  4 in total

1.  Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens.

Authors:  Hadas Zachor; Rhoderick Machekano; Michelle M Estrella; Peter J Veldkamp; Michele D Zeier; Olalekan A Uthman; Jantjie J Taljaard; Mohammed R Moosa; Jean B Nachega
Journal:  AIDS       Date:  2016-05-15       Impact factor: 4.177

2.  Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal.

Authors:  Adrià Ramírez Mena; Judicaël M Tine; Louise Fortes; Ousseynou Ndiaye; Daye Ka; Ndeye Fatou Ngom; Alban Ramette; Pascal Bittel; Moussa Seydi; Gilles Wandeler
Journal:  J Viral Hepat       Date:  2021-10-05       Impact factor: 3.517

Review 3.  Underutilisation of routinely collected data in the HIV programme in Zambia: a review of quantitatively analysed peer-reviewed articles.

Authors:  Tendai Munthali; Patrick Musonda; Paul Mee; Sehlulekile Gumede; Ab Schaap; Alwyn Mwinga; Caroline Phiri; Nathan Kapata; Charles Michelo; Jim Todd
Journal:  Health Res Policy Syst       Date:  2017-06-13

4.  Incidence and predictors of tenofovir disoproxil fumarate-induced renal impairment in HIV infected Nigerian patients.

Authors:  Bazim V Ojeh; Isaac O Abah; Placid Ugoagwu; Patricia A Agaba; Oche O Agbaji; Steven S Gyang
Journal:  Germs       Date:  2018-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.